• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胚胎干细胞在OP9基质细胞上分化为淋巴管内皮细胞。

Differentiation of lymphatic endothelial cells from embryonic stem cells on OP9 stromal cells.

作者信息

Kono Tomoya, Kubo Hajime, Shimazu Chikashi, Ueda Yoshihide, Takahashi Meiko, Yanagi Kentoku, Fujita Naoya, Tsuruo Takashi, Wada Hiromi, Yamashita Jun K

机构信息

Molecular and Cancer Research Unit, HMRO, Graduate School of Medicine, Kyoto University, Yoshida-Konoe-cho, Sakyo-ku, Kyoto, 606-8501, Japan.

出版信息

Arterioscler Thromb Vasc Biol. 2006 Sep;26(9):2070-6. doi: 10.1161/01.ATV.0000225770.57219.b0. Epub 2006 May 11.

DOI:10.1161/01.ATV.0000225770.57219.b0
PMID:16690875
Abstract

OBJECTIVE

The discovery of vascular endothelial growth factor C (VEGF-C) and VEGF receptor-3 (VEGFR-3) has started to provide an understanding of the molecular mechanisms of lymphangiogenesis. The homeobox gene prox1 has been proven to specify lymphatic endothelial cells (ECs) from blood ECs. We investigated the process of lymphatic EC (LEC) differentiation using embryonic stem (ES) cells.

METHODS AND RESULTS

VEGFR-2+ cells derived from ES cells differentiated into LECs at day 3 on OP9 stromal cells defined by the expression of prox1, VEGFR-3, and another lymphatic marker podoplanin. VEGFR-2+ cells gave rise to LYVE-1+ embryonic ECs, which were negative for prox1 on day 1 but turned to prox1+ LECs by day 3. VEGFR-3-Fc or Tie2-Fc, sequestering VEGF-C or angiopoietin1 (Ang1), suppressed colony formation of LECs on OP9 cells. However, addition of VEGF-C and Ang1 in combination with VEGF to the culture of VEGFR-2+ cells on collagen-coated dishes failed to induce LECs. LEC-inducing activity of OP9 cells was fully reproduced on paraformaldehyde-fixed OP9 cells with the conditioned medium.

CONCLUSIONS

We succeeded in differentiating LECs from ES cells and revealed the requirements of VEGF-C, Ang1, and other unknown factors for LEC differentiation.

摘要

目的

血管内皮生长因子C(VEGF-C)和VEGF受体-3(VEGFR-3)的发现开始让人们了解淋巴管生成的分子机制。同源框基因prox1已被证明可将血液内皮细胞(ECs)特化为淋巴管内皮细胞。我们利用胚胎干细胞(ES细胞)研究了淋巴管内皮细胞(LEC)的分化过程。

方法与结果

源自ES细胞的VEGFR-2+细胞在OP9基质细胞上培养3天时分化为LEC,其依据为prox1、VEGFR-3和另一种淋巴管标志物血小板内皮细胞黏附分子-1的表达情况。VEGFR-2+细胞产生LYVE-1+胚胎ECs,其在第1天时prox1呈阴性,但到第3天时转变为prox1+LEC。VEGFR-3-Fc或Tie2-Fc可隔离VEGF-C或血管生成素1(Ang1),从而抑制LEC在OP9细胞上的集落形成。然而,在胶原包被培养皿上培养VEGFR-2+细胞时,将VEGF-C和Ang1与VEGF联合添加并不能诱导产生LEC。OP9细胞的LEC诱导活性在经多聚甲醛固定的OP9细胞与条件培养基共同作用下可完全重现。

结论

我们成功地从ES细胞中分化出LEC,并揭示了VEGF-C、Ang1和其他未知因子对LEC分化的需求。

相似文献

1
Differentiation of lymphatic endothelial cells from embryonic stem cells on OP9 stromal cells.胚胎干细胞在OP9基质细胞上分化为淋巴管内皮细胞。
Arterioscler Thromb Vasc Biol. 2006 Sep;26(9):2070-6. doi: 10.1161/01.ATV.0000225770.57219.b0. Epub 2006 May 11.
2
Tumor-induced activation of lymphatic endothelial cells via vascular endothelial growth factor receptor-2 is critical for prostate cancer lymphatic metastasis.肿瘤通过血管内皮生长因子受体-2诱导淋巴管内皮细胞活化对前列腺癌淋巴转移至关重要。
Cancer Res. 2006 Oct 1;66(19):9566-75. doi: 10.1158/0008-5472.CAN-06-1488.
3
Early lymph vessel development from embryonic stem cells.胚胎干细胞早期淋巴管发育
Arterioscler Thromb Vasc Biol. 2006 May;26(5):1073-8. doi: 10.1161/01.ATV.0000217610.58032.b7. Epub 2006 Mar 16.
4
Different differentiation kinetics of vascular progenitor cells in primate and mouse embryonic stem cells.灵长类和小鼠胚胎干细胞中血管祖细胞的不同分化动力学
Circulation. 2003 Apr 29;107(16):2085-8. doi: 10.1161/01.CIR.0000070022.78747.1B. Epub 2003 Apr 21.
5
Vascular endothelial growth factor-C secreted by pancreatic cancer cell line promotes lymphatic endothelial cell migration in an in vitro model of tumor lymphangiogenesis.胰腺癌细胞系分泌的血管内皮生长因子-C在肿瘤淋巴管生成的体外模型中促进淋巴管内皮细胞迁移。
Pancreas. 2007 May;34(4):444-51. doi: 10.1097/mpa.0b13e31803dd307.
6
Adrenomedullin/cyclic AMP pathway induces Notch activation and differentiation of arterial endothelial cells from vascular progenitors.肾上腺髓质素/环磷酸腺苷途径诱导Notch激活以及血管祖细胞向动脉内皮细胞的分化。
Arterioscler Thromb Vasc Biol. 2006 Sep;26(9):1977-84. doi: 10.1161/01.ATV.0000234978.10658.41. Epub 2006 Jun 29.
7
Shb promotes blood vessel formation in embryoid bodies by augmenting vascular endothelial growth factor receptor-2 and platelet-derived growth factor receptor-beta signaling.Shb通过增强血管内皮生长因子受体-2和血小板衍生生长因子受体-β信号传导来促进胚状体中的血管形成。
Exp Cell Res. 2005 Aug 15;308(2):381-93. doi: 10.1016/j.yexcr.2005.04.020.
8
[In vitro vasculogenesis and angiogenesis of mouse embryonic stem cells].[小鼠胚胎干细胞的体外血管生成与血管新生]
Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2005 Feb;27(1):62-6.
9
Directed and systematic differentiation of cardiovascular cells from mouse induced pluripotent stem cells.从小鼠诱导多能干细胞定向和系统分化心血管细胞。
Circulation. 2008 Jul 29;118(5):498-506. doi: 10.1161/CIRCULATIONAHA.108.769562. Epub 2008 Jul 14.
10
Identification and characterization of hemoangiogenic progenitors during cynomolgus monkey embryonic stem cell differentiation.食蟹猴胚胎干细胞分化过程中血管生成祖细胞的鉴定与特征分析
Stem Cells. 2006 May;24(5):1348-58. doi: 10.1634/stemcells.2005-0165. Epub 2006 Jan 12.

引用本文的文献

1
A pluripotent stem cell model of Emberger syndrome reveals reduced lymphatic endothelial differentiation.恩伯格综合征的多能干细胞模型显示淋巴管内皮分化降低。
Int J Hematol. 2025 May 28. doi: 10.1007/s12185-025-04004-1.
2
Tissue-Engineered Therapeutics for Lymphatic Regeneration: Solutions for Myocardial Infarction and Secondary Lymphedema.用于淋巴再生的组织工程疗法:心肌梗死和继发性淋巴水肿的解决方案
Adv Healthc Mater. 2025 Mar;14(6):e2403551. doi: 10.1002/adhm.202403551. Epub 2025 Jan 13.
3
Robust Differentiation of Human Pluripotent Stem Cells into Lymphatic Endothelial Cells Using Transcription Factors.
利用转录因子将人多能干细胞高效分化为淋巴管内皮细胞
Cells Tissues Organs. 2024;213(6):464-474. doi: 10.1159/000539699. Epub 2024 Aug 28.
4
Bioengineering of Intestinal Grafts.肠道移植物的生物工程。
Gastroenterol Clin North Am. 2024 Sep;53(3):461-472. doi: 10.1016/j.gtc.2023.12.006. Epub 2024 Jan 23.
5
Synthetic hyaluronic acid coating preserves the phenotypes of lymphatic endothelial cells.合成透明质酸涂层可保持淋巴管内皮细胞的表型。
Biomater Sci. 2023 Nov 7;11(22):7346-7357. doi: 10.1039/d3bm00873h.
6
Therapeutic Lymphangiogenesis Is a Promising Strategy for Secondary Lymphedema.治疗性淋巴管生成术是治疗继发性淋巴水肿的一种有前途的策略。
Int J Mol Sci. 2023 Apr 24;24(9):7774. doi: 10.3390/ijms24097774.
7
Modeling lymphangiogenesis: Pairing in vitro and in vivo metrics.淋巴管生成建模:体外和体内度量标准的配对。
Microcirculation. 2023 Apr;30(2-3):e12802. doi: 10.1111/micc.12802. Epub 2023 Feb 28.
8
Lymphatic Tissue Bioengineering for the Treatment of Postsurgical Lymphedema.用于治疗术后淋巴水肿的淋巴组织生物工程
Bioengineering (Basel). 2022 Apr 6;9(4):162. doi: 10.3390/bioengineering9040162.
9
Lymphatic Tissue and Organ Engineering for In Vitro Modeling and In Vivo Regeneration.用于体外建模和体内再生的淋巴组织与器官工程
Cold Spring Harb Perspect Med. 2022 Mar 14;12(9). doi: 10.1101/cshperspect.a041169.
10
Building gut from scratch - progress and update of intestinal tissue engineering.从头开始构建肠道 - 肠道组织工程的进展和更新。
Nat Rev Gastroenterol Hepatol. 2022 Jul;19(7):417-431. doi: 10.1038/s41575-022-00586-x. Epub 2022 Mar 3.